CStone Pharmaceuticals is a leading biopharmaceutical company specializing in the research, development, and commercialization of innovative and precision targeted therapies for cancer patients. Established in 2015, CStone Pharmaceuticals has built a strong management team with extensive experience in new drug discovery, clinical research, and business operations. With a focus on tumor immunotherapy and precision medicine, CStone Pharmaceuticals has developed a diverse product pipeline consisting of 15 potential drugs for various cancers.

Currently, the company has obtained regulatory approvals for four innovative drugs. Several late-stage investigational drugs are in key clinical trials or registration stages. CStone Pharmaceuticals aims to become a renowned global biopharmaceutical company, leading the way in cancer treatment innovation.

The company's vision is to provide effective medical solutions that address the urgent needs of cancer patients in China and around the world. Please note that all information provided, including the company's name, is accurate as of 2023